Gilead Sciences (GILD) Operating Margin (2016 - 2025)
Historic Operating Margin for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 42.82%.
- Gilead Sciences' Operating Margin rose 310500.0% to 42.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.06%, marking a year-over-year increase of 331600.0%. This contributed to the annual value of 5.78% for FY2024, which is 222700.0% down from last year.
- Latest data reveals that Gilead Sciences reported Operating Margin of 42.82% as of Q3 2025, which was up 310500.0% from 34.93% recorded in Q2 2025.
- In the past 5 years, Gilead Sciences' Operating Margin ranged from a high of 51.77% in Q3 2021 and a low of 64.64% during Q1 2024
- For the 5-year period, Gilead Sciences' Operating Margin averaged around 25.95%, with its median value being 32.41% (2022).
- In the last 5 years, Gilead Sciences' Operating Margin plummeted by -914800bps in 2024 and then skyrocketed by 982000bps in 2025.
- Quarter analysis of 5 years shows Gilead Sciences' Operating Margin stood at 12.98% in 2021, then skyrocketed by 136bps to 30.68% in 2022, then fell by -26bps to 22.66% in 2023, then soared by 43bps to 32.4% in 2024, then soared by 32bps to 42.82% in 2025.
- Its last three reported values are 42.82% in Q3 2025, 34.93% for Q2 2025, and 33.55% during Q1 2025.